Renal vein levels of MicroRNA-26a are lower in the poststenotic kidney

Journal of the American Society of Nephrology

Volumn 26, Issue 6, 2015, Pages 1378-1388

  Zhu, Xiang Yang ^a   Ebrahimi, Behzad ^a   Eirin, Alfonso ^a   Woollard, John R ^a   Tang, Hui ^a   Jordan, Kyra L ^a   Ofori, Michael ^a   Saad, Ahmed ^a   Herrmann, Sandra M S ^a   Dietz, Allan B ^a   Textor, Stephen C ^a   Lerman, Amir ^a   Lerman, Lilach O ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CHOLESTEROL; CREATININE; ENDOGLIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FUROSEMIDE; HERMES ANTIGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 10; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MICRORNA 26A; MYELOPEROXIDASE; PROTEIN; THY 1 ANTIGEN; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; MICRORNA;

AGED; ANGIOGRAPHY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; COCULTURE; COMPARATIVE STUDY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE URINE LEVEL; ESSENTIAL HYPERTENSION; EX VIVO STUDY; FEMALE; FIBROSING ALVEOLITIS; FLOW CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; GLOMERULOSCLEROSIS; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; KIDNEY ARTERY STENOSIS; KIDNEY DISEASE; KIDNEY FUNCTION; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE CELL; KIDNEY VEIN; MALE; MESENCHYMAL STEM CELL; MICRO-COMPUTED TOMOGRAPHY; NONHUMAN; PIG; POSTSTENOTIC KIDNEY; PRESSURE GRADIENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN URINE LEVEL; RENAL VASCULAR DISEASE; RENOVASCULAR HYPERTENSION; TRIACYLGLYCEROL BLOOD LEVEL; UMBILICAL VEIN ENDOTHELIAL CELL; UPREGULATION; VASCULAR DISEASE; ACUTE KIDNEY INJURY; ANALYSIS OF VARIANCE; ANIMAL; BLOOD; CASE CONTROL STUDY; CELL CULTURE; DISEASE MODEL; KIDNEY FUNCTION TEST; MESENCHYMAL STEM CELL TRANSPLANTATION; METABOLISM; NEEDLE BIOPSY; PATHOLOGY; PROCEDURES; REFERENCE VALUE; RENAL ARTERY OBSTRUCTION; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

ACUTE KIDNEY INJURY; AGED; ANALYSIS OF VARIANCE; ANIMALS; BIOPSY, NEEDLE; CASE-CONTROL STUDIES; CELLS, CULTURED; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY FUNCTION TESTS; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MICRORNAS; REFERENCE VALUES; RENAL ARTERY OBSTRUCTION; RENAL VEINS; SEVERITY OF ILLNESS INDEX; SWINE; TREATMENT OUTCOME;

EID: 84930437267     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2014030248     Document Type: Article

References (39)

1. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, McCullough PA, Kasiske BL, Kelepouris E, Klag MJ, Parfrey P, Pfeffer M, Raij L, Spinosa DJ, Wilson PW; American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention: Kidney disease as a risk factor for development of cardiovascular disease: A statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 108: 2154-2169, 2003
2. Chade AR, Mushin OP, Zhu X, Rodriguez-Porcel M, Grande JP, Textor SC, Lerman A, Lerman LO: Pathways of renal fibrosis and modulation of matrix turnover in experimental hypercholesterolemia. Hypertension 46: 772-779, 2005
3. Chade AR, Zhu X, Mushin OP, Napoli C, Lerman A, Lerman LO: Simvastatin promotes angiogenesis and prevents microvascular remodeling in chronic renal ischemia. FASEB J 20: 1706-1708, 2006
4. Zhu XY, Chade AR, Krier JD, Daghini E, Lavi R, Guglielmotti A, Lerman A, Lerman LO: The chemokine monocyte chemoattractant protein-1 contributes to renal dysfunction in swine renovascular hypertension. J Hypertens 27: 2063-2073, 2009
5. Schroen B, Heymans S: Small but smart - microRNAs in the centre of inflammatory processes during cardiovascular diseases, the metabolic syndrome, and ageing. Cardiovasc Res 93: 605-613, 2012
6. Jakob P, Landmesser U: Role of microRNAs in stem/progenitor cells and cardiovascular repair. Cardiovasc Res 93: 614-622, 2012
7. Leeper NJ, Raiesdana A, Kojima Y, Chun HJ, Azuma J, Maegdefessel L, Kundu RK, Quertermous T, Tsao PS, Spin JM: MicroRNA-26a is a novel regulator of vascular smooth muscle cell function. J Cell Physiol 226: 1035-1043, 2011
8. Icli B, Wara AK, Moslehi J, Sun X, Plovie E, Cahill M, Marchini JF, Schissler A, Padera RF, Shi J, Cheng HW, Raghuram S, Arany Z, Liao R, Croce K, MacRae C, Feinberg MW: MicroRNA-26a regulates pathological and physiological angiogenesis by targeting BMP/SMAD1 signaling. Circ Res 113: 1231-1241, 2013
9. Ho J, Ng KH, Rosen S, Dostal A, Gregory RI, Kreidberg JA: Podocyte-specific loss of functional microRNAs leads to rapid glomerular and tubular injury. J Am Soc Nephrol 19: 2069-2075, 2008
10. Chade AR, Zhu X, Lavi R, Krier JD, Pislaru S, Simari RD, Napoli C, Lerman A, Lerman LO: Endothelial progenitor cells restore renal function in chronic experimental renovascular disease. Circulation 119: 547-557, 2009
11. Eirin A, Zhu XY, Krier JD, Tang H, Jordan KL, Grande JP, Lerman A, Textor SC, Lerman LO: Adipose tissue-derived mesenchymal stem cells improve revascularization outcomes to restore renal function in swine atherosclerotic renal artery stenosis. Stem Cells 30: 1030-1041, 2012
12. Ebrahimi B, Eirin A, Li Z, Zhu XY, Zhang X, Lerman A, Textor SC, Lerman LO: Mesenchymal stem cells improve medullary inflammation and fibrosis after revascularization of swine atherosclerotic renal artery stenosis. PLoS ONE 8: e67474, 2013
13. Zhu XY, Urbieta-Caceres V, Krier JD, Textor SC, Lerman A, Lerman LO: Mesenchymal stem cells and endothelial progenitor cells decrease renal injury in experimental swine renal artery stenosis through different mechanisms. Stem Cells 31: 117-125, 2013
14. Tögel F, Cohen A, Zhang P, Yang Y, Hu Z, Westenfelder C: Autologous and allogeneic marrow stromal cells are safe and effective for the treatment of acute kidney injury. Stem Cells Dev 18: 475-485, 2009
15. Choi S, Park M, Kim J, Hwang S, Park S, Lee Y: The role of mesenchymal stem cells in the functional improvement of chronic renal failure. Stem Cells Dev 18: 521-529, 2009
16. Semedo P, Correa-Costa M, Antonio Cenedeze M, Maria Avancini Costa Malheiros D, Antonia dos Reis M, Shimizu MH, Seguro AC, Pacheco-Silva A, Saraiva Camara NO: Mesenchymal stem cells attenuate renal fibrosis through immune modulation and remodeling properties in a rat remnant kidney model. Stem Cells 27: 3063-3073, 2009
17. Collino F, Deregibus MC, Bruno S, Sterpone L, Aghemo G, Viltono L, Tetta C, Camussi G: Microvesicles derived from adult human bone marrow and tissue specific mesenchymal stem cells shuttle selected pattern of miRNAs. PLoS ONE 5: e11803, 2010
18. Ahmed T, Tripathi AK, Ahmed RS, Das S, Suke SG, Pathak R, Chakraboti A, Banerjee BD: Endosulfan-induced apoptosis and glutathione depletion in human peripheral blood mononuclear cells: Attenuation by N-acetylcysteine. J Biochem Mol Toxicol 22: 299-304, 2008
19. Dai Y, Sui W, Lan H, Yan Q, Huang H, Huang Y: Comprehensive analysis of microRNA expression patterns in renal biopsies of lupus nephritis patients. Rheumatol Int 29: 749-754, 2009
20. Juan D, Alexe G, Antes T, Liu H, Madabhushi A, Delisi C, Ganesan S, Bhanot G, Liou LS: Identification of a microRNA panel for clear-cell kidney cancer. Urology 75: 835-841, 2010
21. Krupa A, Jenkins R, Luo DD, Lewis A, Phillips A, Fraser D: Loss of MicroRNA-192 promotes fibrogenesis in diabetic nephropathy. J Am Soc Nephrol 21: 438-447, 2010
22. Glowacki F, Savary G, Gnemmi V, Buob D, Van der Hauwaert C, Lo-Guidice JM, Bouyé S, Hazzan M, Pottier N, Perrais M, Aubert S, Cauffiez C: Increased circulating miR-21 levels are associated with kidney fibrosis. PLoS ONE 8: e58014, 2013
23. Taïbi F, Metzinger-Le Meuth V, M'Baya-Moutoula E, Djelouat M, Louvet L, Bugnicourt JM, Poirot S, Bengrine A, Chillon JM, Massy ZA, Metzinger L: Possible involvement of microRNAs in vascular damage in experimental chronic kidney disease. Biochim Biophys Acta 1842: 88-98, 2014
24. Jia P, Teng J, Zou J, Fang Y, Zhang X, Bosnjak ZJ, Liang M, Ding X: miR-21 contributes to xenon-conferred amelioration of renal ischemia-reperfusion injury in mice. Anesthesiology 119: 621-630, 2013
25. Chang W, Lee CY, Park JH, Park MS, Maeng LS, Yoon CS, Lee MY, Hwang KC, Chung YA: Survival of hypoxic human mesenchymal stem cells is enhanced by a positive feedback loop involving miR-210 and hypoxia-inducible factor 1. J Vet Sci 14: 69-76, 2013
26. Lieberthal W, Rennke HG, Sandock KM, Valeri CR, Levinsky NG: Ischemia in the isolated erythrocyte-perfused rat kidney. Protective effect of hypothermia. Ren Physiol Biochem 11: 60-69, 1988
27. Molitoris BA: Acute renal failure. Drugs Today (Barc) 35:659-666, 1999
28. Havasi A, Borkan SC: Apoptosis and acute kidney injury. Kidney Int 80: 29-40, 2011
29. Ruan W, Xu JM, Li SB, Yuan LQ, Dai RP: Effects of down-regulation of microRNA-23a on TNF-α-induced endothelial cell apoptosis through caspase-dependent pathways. Cardiovasc Res 93: 623-632, 2012
30. Wei C, Kim IK, Kumar S, Jayasinghe S, Hong N, Castoldi G, Catalucci D, Jones WK, Gupta S: NF-κB mediated miR-26a regulation in cardiac fibrosis. J Cell Physiol 228: 1433-1442, 2013
31. Gloviczki ML, Glockner JF, Lerman LO, McKusick MA, Misra S, Grande JP, Textor SC: Preserved oxygenation despite reduced blood flow in poststenotic kidneys in human atherosclerotic renal artery stenosis. Hypertension 55: 961-966, 2010
32. Zhu XY, Chade AR, Rodriguez-Porcel M, Bentley MD, Ritman EL, Lerman A, Lerman LO: Cortical microvascular remodeling in the stenotic kidney: Role of increased oxidative stress. Arterioscler Thromb Vasc Biol 24: 1854-1859, 2004
33. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop D, Horwitz E: Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8: 315-317, 2006
34. Oswald J, Boxberger S, Jørgensen B, Feldmann S, Ehninger G, Bornhäuser M, Werner C: Mesenchymal stem cells can be differentiated into endothelial cells in vitro. Stem Cells 22: 377-384, 2004
35. Ebrahimi B, Gloviczki M, Woollard JR, Crane JA, Textor SC, Lerman LO: Compartmental analysis of renal BOLD MRI data: Introduction and validation. Invest Radiol 47: 175-182, 2012
36. Chade AR, Zhu XY, Krier JD, Jordan KL, Textor SC, Grande JP, Lerman A, Lerman LO: Endothelial progenitor cells homing and renal repair in experimental renovascular disease. Stem Cells 28: 1039-1047, 2010
37. Chade AR, Rodriguez-Porcel M, Grande JP, Krier JD, Lerman A, Romero JC, Napoli C, Lerman LO: Distinct renal injury in early atherosclerosis and renovascular disease. Circulation 106: 1165-1171, 2002
38. Zhang X, Li ZL, Woollard JR, Eirin A, Ebrahimi B, Crane JA, Zhu XY, Pawar AS, Krier JD, Jordan KL, Tang H, Textor SC, Lerman A, Lerman LO: Obesity-metabolic derangement preserves hemodynamics but promotes intrarenal adiposity and macrophage infiltration in swine renovascular disease. Am J Physiol Renal Physiol 305: F265-F276, 2013
39. Saad A, Crane J, Glockner JF, Herrmann SM, Friedman H, Ebrahimi B, Lerman LO, Textor SC: Human renovascular disease: Estimating fractional tissue hypoxia to analyze blood oxygen level-dependent MR. Radiology 268: 770-778, 2013